As of 2025-09-16, the Relative Valuation of Alexion Pharmaceuticals Inc (ALXN) is 46.63 USD. This relative valuation is based on P/E multiples. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on Relative Valuation is -74.4%.
The range of the Relative Valuation is 34.32 - 54.69 USD.
| Range | Selected | |
| Trailing P/E multiples | 15.0x - 17.8x | 16.6x |
| Forward P/E multiples | 13.2x - 18.9x | 16.2x |
| Fair Price | 34.32 - 54.69 | 46.63 |
| Upside | -81.2% - -70.0% | -74.4% |
| Date | P/E |